oral DNA-PK inhibitor

Ph. I/II candidate for advanced tumors

from screening for selectivity vs. PI3Ka

Mol. Cancer Ther.


oral DNA-PK inhibitor - AstraZeneca

Context. AZD7648 (AstraZeneca) is an oral DNA-PK inhibitor. DNA-PK, ATR, and ATM are all kinases involved in DNA damage repair and have been of significant recent interest due to…

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: